The Scientist

» media relations and disease/medicine

Most Recent

image: Viral Soldiers

Viral Soldiers

By | January 1, 2016

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

11 Comments

image: Second Contagious Cancer Found in Tasmanian Devils

Second Contagious Cancer Found in Tasmanian Devils

By | December 29, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

0 Comments

image: Year in Review: Hot Topics

Year in Review: Hot Topics

By | December 21, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

0 Comments

image: When the Flu Vax Fails

When the Flu Vax Fails

By | December 16, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

0 Comments

image: Global Food-Related Disease Estimate

Global Food-Related Disease Estimate

By | December 7, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

0 Comments

image: The Regenerator

The Regenerator

By | December 1, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

0 Comments

image: BRCA1 Linked to Alzheimer’s

BRCA1 Linked to Alzheimer’s

By | November 30, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

0 Comments

image: Cortical Census

Cortical Census

By | November 26, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

1 Comment

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

0 Comments

image: How Gastric Bypass Can Kill Sugar Cravings

How Gastric Bypass Can Kill Sugar Cravings

By | November 19, 2015

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech